Edward Roberts

4.4k citations

89 papers · 3.2k indexed · 1 hit paper · h-index 31

Impact in

Cellular and Molecular Neuroscience top 2%
- Neuropeptides and Animal Physiology
Biological Psychiatry top 5%

Papers in

Cellular and Molecular Neuroscience 29
- Neuropeptides and Animal Physiology 27
Behavioral Neuroscience 5

Co-authors: Hugh Rosen Miguel Guerrero Fiona L. Scott Esther Martinborough Robert Peach Kevin B. Walsh David C. Horwell Mariangela Urbano
Journals: Bioorganic & Medicinal Chemistry Letters (21 papers)Tetrahedron Letters (7 papers)Journal of Medicinal Chemistry (4 papers)Molecular Pharmacology (3 papers)Organic Letters (3 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Edward Roberts

87 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection 2011 · 556 citations

Peers

Countries citing papers authored by Edward Roberts

Since Specialization

Citations

This map shows the geographic impact of Edward Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Roberts more than expected).

Fields of papers citing papers by Edward Roberts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Roberts. The network helps show where Edward Roberts may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Edward Roberts, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edward Roberts Line = papers co-authored together Edward Roberts links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Opposing Effects on Descending Control of Nociception by µ and κ Opioid Receptors in the Anterior Cingulate Cortex Anesthesiology ·Edita Navratilova, Chaoling Qu, Guangchen Ji, Volker Neugebauer, Miguel Guerrero, Hugh Rosen, Edward Roberts, Frank Porreca	2023	11
2	Genetic and Pharmacologic Manipulation of TLR4 Has Minimal Impact on Ethanol Consumption in Rodents PMC ·R. Adron Harris, Michal Bajo, Richard L. Bell, Yuri A. Blednov, Florence P. Varodayan, Jay Truitt, Giordano de Guglielmo, Amy W. Lasek, Marian L. Logrip, Leandro F. Vendruscolo, Amanda J. Roberts, Edward Roberts, Olivier George, Jody Mayfield, Timothy R. Billiar, David J. Hackam, R. Dayne Mayfield, George F. Koob, Marisa Roberto, Gregg E. Homanics	2017	2
3	Ozanimod (RPC1063) is a potent sphingosine‐1‐phosphate receptor‐1 (S1P ₁ ) and receptor‐5 (S1P ₅ ) agonist with autoimmune disease‐modifying activity British Journal of Pharmacology ·Fiona L. Scott, Bryan Clemons, Jennifer L. Brooks, Enugurthi Brahmachary, Rachel Powell, Harry Dedman, Ganesh Durgachalam N, Gregg Timony, Esther Martinborough, Hugh Rosen, Edward Roberts, Marcus F. Boehm, Robert Peach	2016	239
4	Antagonists of the kappa opioid receptor Bioorganic & Medicinal Chemistry Letters ·Mariangela Urbano, Miguel Guerrero, Hugh Rosen, Edward Roberts	2014	57
5	Visual-vestibular interaction: basic science to clinical relevance Edward Roberts, Adolfo M. Bronstein, Barry M. Seemungal	2013	4
6	Discovery, design and synthesis of a selective S1P3 receptor allosteric agonist Bioorganic & Medicinal Chemistry Letters ·Miguel Guerrero, 潘海平, Mariangela Urbano, Xuemei Peng, Timothy Spicer, Peter Chase, Peter Hodder, Marie‐Therese Schaeffer, Steven J Brown, Hugh Rosen, Edward Roberts	2013	13
7	Sphingosine 1-phosphate receptor agonists: a patent review (2010 – 2012) Expert Opinion on Therapeutic Patents ·Edward Roberts, Miguel Guerrero, Mariangela Urbano, Hugh Rosen	2013	38
8	Design, synthesis and SAR analysis of novel potent and selective small molecule antagonists of NPBWR1 (GPR7) Bioorganic & Medicinal Chemistry Letters ·Mariangela Urbano, Miguel Guerrero, L.V.A. Werstein, Subash Velaparthi, S. Adrian Saldanha, Peter Chase, Zhiwei Wang, Olivier Civelli, Peter Hodder, Marie‐Therese Schaeffer, Steven J Brown, Hugh Rosen, Edward Roberts	2012	8
9	Sphingosine 1-Phosphate Receptor 1 (S1P1) Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist Molecular Pharmacology ·Stuart M. Cahalan, Pedro J. Gonzalez‐Cabrera, Nhan Nguyen, Miguel Guerrero, Jan F. M. de Rooy, Nora B. Leaf, Steven J Brown, Edward Roberts, Hugh Rosen	2012	31
10	Discovery, design and synthesis of the first reported potent and selective sphingosine-1-phosphate 4 (S1P4) receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Miguel Guerrero, Mariangela Urbano, Subash Velaparthi, L.V.A. Werstein, Marie‐Therese Schaeffer, Steven J Brown, Hugh Rosen, Edward Roberts	2011	30
11	N,N-Diethyl-4-[(3-hydroxyphenyl)(piperidin-4-yl)amino] benzamide derivatives: The development of diaryl amino piperidines as potent δ opioid receptor agonists with in vivo anti-nociceptive activity in rodent models Bioorganic & Medicinal Chemistry Letters ·Paul A. Jones, Andrew M. Griffin, Lars Gawell, Marolop Simanullang, Daniel Delorme, Edward Roberts, W. A. Brown, Christopher Walpole, V. Maquet, Jamie Boulet, Maryse Labarre, Alexandre Mass, Joanne Butterworth, Stéphane St-Onge, Guger Christoph, T Zeltner	2009	12
12	Local Not Systemic Modulation of Dendritic Cell S1P Receptors in Lung Blunts Virus-Specific Immune Responses to Influenza Molecular Pharmacology ·David Marsolais, Bumsuk Hahm, Kurt H. Edelmann, Kevin B. Walsh, Miguel Guerrero, Yasuko Hatta, Yoshihiro Kawaoka, Edward Roberts, Michael B. A. Oldstone, Hugh Rosen	2008	60
13	Full Pharmacological Efficacy of a Novel S1P1 Agonist That Does Not Require S1P-Like Headgroup Interactions Molecular Pharmacology ·Pedro J. Gonzalez‐Cabrera, Euijung Jo, Marta Sanna, Steven J Brown, Nora B. Leaf, David Marsolais, Marie‐Therese Schaeffer, 慈子出水, Michael D. Cameron, Miguel Guerrero, Edward Roberts, Hugh Rosen	2008	103
14	Ground Resonance History of the H-34 Helicopter V Mahadevan, Andrew G. Mark, ⁄ Wood, Edward Roberts	2007	1
15	Lead Generation - Enhancing the Success of Drug Discovery by Investing in the Hit to Lead Process Combinatorial Chemistry & High Throughput Screening ·Alexander Alanine, Matthias Nettekoven, Edward Roberts, Andrew W. Thomas	2003	38
16	Novel “Restoration of Function” Mutagenesis Strategy to Identify Amino Acids of the δ-Opioid Receptor Involved in Ligand Binding Journal of Biological Chemistry ·I.E. Dovgij, Shi Yi Yue, Edward Roberts, Claes Wahlestedt, Philippe Walker	1997	47
17	Eliminating needless testing in intensive care—An information-based team management approach Critical Care Medicine ·Daniel Roberts, Dean D. Bell, Angel Elvira, Karen Dobson, L. Oppenheimer, C. Lippi, Rudramuneswara Swamy B P, Sophia Reinders, Laura Coppini, Burcu Melikoğlu, Hans-Peter F. Grossart, Vicky Pliaka, Edward Roberts, Arthur F. Ewing	1993	49
18	Conformationally restricted analogues of the potent CCK-B antagonist CI-988 Bioorganic & Medicinal Chemistry ·Michael Higginbottom, DR Hill, David C. Horwell, Olha Stanislavivna Basarab, Nirmala Suman‐Chauhan, Edward Roberts	1993	7
19	Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and mixed CCK-A/CCK-B antagonists Journal of Medicinal Chemistry ·P. Boden, Michael Higginbottom, David R. Hill, David C. Horwell, Jonathan Hughes, David C. Rees, Edward Roberts, L. Singh, Nirmala Suman‐Chauhan, G.N. Woodruff	1993	56
20	Rationally designed "dipeptoid" analogs of CCK. .alpha.-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties Journal of Medicinal Chemistry ·David C. Horwell, Jonathan Hughes, JC Hunter, Martyn C. Pritchard, Russell S. Richardson, Edward Roberts, G.N. Woodruff	1991	142

About Edward Roberts

Edward Roberts is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience, Biological Psychiatry, Molecular Biology and Organic Chemistry, having authored 89 papers that have together received 3.2k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (31 papers), Neuropeptides and Animal Physiology (27 papers), Sphingolipid Metabolism and Signaling (19 papers), Chemical Synthesis and Analysis (12 papers), Lipid Membrane Structure and Behavior (11 papers), Asymmetric Synthesis and Catalysis (10 papers), Pharmacological Receptor Mechanisms and Effects (8 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (734 citations), Biological Psychiatry (82 citations), Molecular Biology (1.8k citations), Behavioral Neuroscience (92 citations) and Immunology (523 citations). Edward Roberts has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Hugh Rosen, Miguel Guerrero, Fiona L. Scott, Esther Martinborough, Robert Peach, Kevin B. Walsh, David C. Horwell, Mariangela Urbano, Stuart M. Cahalan and John R. Teijaro. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Journal of Medicinal Chemistry, Molecular Pharmacology and Organic Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact